Cecilia Furlong
Stock Analyst at Morgan Stanley
(2.28)
# 1,448
Out of 4,414 analysts
171
Total ratings
40.51%
Success rate
-2.49%
Average return
Main Sectors:
Top Industries:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $117.60 | -19.22% | 12 | Feb 28, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $120 → $125 | $119.56 | +4.55% | 10 | Dec 4, 2023 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $5.59 | -28.44% | 13 | Dec 4, 2023 | |
| ISRG Intuitive Surgical | Maintains: Equal-Weight | $300 → $330 | $371.70 | -11.22% | 10 | Dec 4, 2023 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $80.89 | +21.15% | 9 | Nov 22, 2023 | |
| EMBC Embecta | Maintains: Underweight | $15 → $16 | $10.13 | +57.95% | 10 | Nov 22, 2023 | |
| NVRO Nevro | Maintains: Equal-Weight | $23 → $18 | $10.41 | +72.91% | 7 | Nov 2, 2023 | |
| AXNX Axonics | Maintains: Overweight | $76 → $69 | $66.87 | +3.19% | 5 | Oct 31, 2023 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $149 → $135 | $111.74 | +20.82% | 13 | Oct 11, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $41.60 | +99.52% | 5 | Aug 3, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $78.53 | +8.24% | 9 | May 11, 2023 | |
| SWAV ShockWave Medical | Maintains: Equal-Weight | $224 → $291 | $329.84 | -11.78% | 6 | May 9, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $20.33 | -26.22% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $170.27 | +101.44% | 3 | May 5, 2023 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $11 → $14 | $7.72 | +81.35% | 7 | May 3, 2023 | |
| BAX Baxter International | Maintains: Equal-Weight | $44 → $48 | $40.34 | +18.99% | 4 | Apr 28, 2023 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $102 | $84.30 | +21.00% | 8 | Apr 27, 2023 | |
| BSX Boston Scientific | Maintains: Overweight | $56 → $58 | $72.21 | -19.68% | 7 | Apr 27, 2023 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $20 | $13.74 | +45.56% | 5 | Feb 23, 2023 | |
| DXCM DexCom | Maintains: Equal-Weight | $117 → $131 | $125.88 | +4.07% | 7 | Jan 6, 2023 | |
| ABT Abbott Laboratories | Maintains: Overweight | $117 → $133 | $106.29 | +25.13% | 11 | Jan 6, 2023 | |
| SYK Stryker | Maintains: Equal-Weight | $270 → $220 | $328.12 | -32.95% | 4 | Jul 15, 2022 | |
| TFX Teleflex | Maintains: Equal-Weight | $383 → $378 | $211.54 | +78.69% | 2 | Feb 25, 2022 |
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $117.60
Upside: -19.22%
Zimmer Biomet Holdings
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $120 → $125
Current: $119.56
Upside: +4.55%
Sight Sciences
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $5.59
Upside: -28.44%
Intuitive Surgical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $300 → $330
Current: $371.70
Upside: -11.22%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $80.89
Upside: +21.15%
Embecta
Nov 22, 2023
Maintains: Underweight
Price Target: $15 → $16
Current: $10.13
Upside: +57.95%
Nevro
Nov 2, 2023
Maintains: Equal-Weight
Price Target: $23 → $18
Current: $10.41
Upside: +72.91%
Axonics
Oct 31, 2023
Maintains: Overweight
Price Target: $76 → $69
Current: $66.87
Upside: +3.19%
iRhythm Technologies
Oct 11, 2023
Maintains: Overweight
Price Target: $149 → $135
Current: $111.74
Upside: +20.82%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $41.60
Upside: +99.52%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $78.53
Upside: +8.24%
ShockWave Medical
May 9, 2023
Maintains: Equal-Weight
Price Target: $224 → $291
Current: $329.84
Upside: -11.78%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $20.33
Upside: -26.22%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $170.27
Upside: +101.44%
Pulmonx
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $7.72
Upside: +81.35%
Baxter International
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $40.34
Upside: +18.99%
Edwards Lifesciences
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $84.30
Upside: +21.00%
Boston Scientific
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $72.21
Upside: -19.68%
Bausch + Lomb
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $13.74
Upside: +45.56%
DexCom
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $125.88
Upside: +4.07%
Abbott Laboratories
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $106.29
Upside: +25.13%
Stryker
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $328.12
Upside: -32.95%
Teleflex
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $211.54
Upside: +78.69%